Insights

Innovative Technology Use Evogene leverages advanced artificial intelligence and big data with its proprietary technological engines, creating opportunities to offer tailored computational biology solutions to biotech firms and agricultural companies seeking to accelerate product development.

Focus on Sustainable Agriculture With subsidiaries working on microbiome therapeutics, ag-chemicals, and biologicals, Evogene presents sales prospects in eco-friendly agricultural inputs and health products, aligning with the increasing demand for sustainable farming and health solutions.

Expanding Market Reach Recent collaborations, such as the partnership with Casterra for high-yield castor varieties, demonstrate Evogene's strategic positioning to expand into scalable, mechanized farming solutions, offering sales avenues in precision agriculture and crop yield optimization.

Financial Growth Potential Though currently in early revenue stages, with a funding of 5.5 million dollars and existing strategic realignment, Evogene is positioned to scale its innovative biotech solutions, creating opportunities to support R&D partnerships and strategic investments.

Industry Alignment Evogene operates in a competitive landscape with major players like Bayer and Syngenta, providing avenues for collaboration or technology licensing, especially in generative design of molecules and microbiome therapeutics to meet rising biotech and sustainable agriculture demands.

Evogene Tech Stack

Evogene uses 8 technology products and services including Atlassian, Kubernetes, NoSQL, and more. Explore Evogene's tech stack below.

  • Atlassian
    Application Development & Management
  • Kubernetes
    Containerization
  • NoSQL
    Database
  • Microsoft 365
    Email
  • JavaScript
    Programming Languages
  • Google Analytics
    Web Analytics
  • LiteSpeed
    Web Servers
  • Nginx
    Web Servers

Media & News

Evogene's Email Address Formats

Evogene uses at least 1 format(s):
Evogene Email FormatsExamplePercentage
First.Last@evogene.comJohn.Doe@evogene.com
79%
FirstL@evogene.comJohnD@evogene.com
13%
Last@evogene.comDoe@evogene.com
4%
First@evogene.comJohn@evogene.com
4%

Frequently Asked Questions

What is Evogene's phone number?

Minus sign iconPlus sign icon
You can contact Evogene's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Evogene's stock symbol?

Minus sign iconPlus sign icon
Evogene is a publicly traded company; the company's stock symbol is EVGN.

What is Evogene's official website and social media links?

Minus sign iconPlus sign icon
Evogene's official website is evogene.com and has social profiles on LinkedInCrunchbase.

What is Evogene's SIC code NAICS code?

Minus sign iconPlus sign icon
Evogene's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evogene have currently?

Minus sign iconPlus sign icon
As of January 2026, Evogene has approximately 108 employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include Ceo: O. H.Chief Agronomist: R. G. ר. ג.Vp Hr: L. F. W. ל. פ. ו.. Explore Evogene's employee directory with LeadIQ.

What industry does Evogene belong to?

Minus sign iconPlus sign icon
Evogene operates in the Biotechnology Research industry.

What technology does Evogene use?

Minus sign iconPlus sign icon
Evogene's tech stack includes AtlassianKubernetesNoSQLMicrosoft 365JavaScriptGoogle AnalyticsLiteSpeedNginx.

What is Evogene's email format?

Minus sign iconPlus sign icon
Evogene's email format typically follows the pattern of First.Last@evogene.com. Find more Evogene email formats with LeadIQ.

How much funding has Evogene raised to date?

Minus sign iconPlus sign icon
As of January 2026, Evogene has raised $5.5M in funding. The last funding round occurred on Aug 23, 2024 for $5.5M.

When was Evogene founded?

Minus sign iconPlus sign icon
Evogene was founded in 2002.

Evogene

Biotechnology ResearchCentral District, Israel51-200 Employees

Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. 
At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs.
Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. We call this approach "Real-World Innovation".
Learn more at: www.evogene.com.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
EVGN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2002
Employees
51-200

Section iconFunding & Financials

  • $5.5M

    Evogene has raised a total of $5.5M of funding over 9 rounds. Their latest funding round was raised on Aug 23, 2024 in the amount of $5.5M.

  • $1M$10M

    Evogene's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $5.5M

    Evogene has raised a total of $5.5M of funding over 9 rounds. Their latest funding round was raised on Aug 23, 2024 in the amount of $5.5M.

  • $1M$10M

    Evogene's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.